MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

- Zheng, Si Min, Feng, Yu Chen, Qi, Teng Fei, Tang, Cai Xia, Zhao, Xiao Hong, Zhang, Yuan Yuan, Xu, Liang, Xu, Ran, Xing, Jun, Baker, Mark, Liu, Tao, Thorne, Rick F., Zhu, Qin, Jin, Lei, Zhang, Xu Dong, Zhang, XD, Cang, S, Gao, JN, Li, Ruo Qi, Yan, Qian Qian, Teng, Liu, Yue, Yi Meng, Han, Man Man, Ye, Kaihong, Zhang, Sheng Nan

Next Directions in the Neuroscience of Cancers Arising outside the CNS

- Amit, Moran, Anastasaki, Corina, Magnon, Claire, Monje, Michelle, Na'ara, Shorook, Pan, Yuan, Repasky, Elizabeth A., Scheff, Nicole N., Sloan, Erica K., Talbot, Sebastien, Tracey, Kevin J., Trotman, Lloyd C., Dantzer, Robert, Valiente, M, Van Aelst, L, Venkataramani, V, Venkatesh, HS, Vermeer, PD, Winkler, F, Wong, RJ, Gutmann, DH, Borniger, JC, Demir, Ihsan Ekin, Deneen, Benjamin, Dixon, Karen O., Egeblad, Mikala, Gibson, Erin M., Hervey-Jumper, Shawn L., Hondermarck, Hubert

Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

- Venneti, Sriram, Kawakibi, Abed Rahman, Ramage, Samuel, Chi, Andrew, Wen, Patrick Y., Arrillaga-Romany, Isabel, Batchelor, Tracy T., Butowski, Nicholas A., Sumrall, Ashley, Shonka, Nicole, Harrison, Rebecca A., de Groot, John, Ji, Sunjong, Mehta, M, Hall, MD, Daghistani, D, Cloughesy, TF, Ellingson, BM, Beccaria, K, Varlet, P, Kim, MM, Umemura, Y, Garton, H, Waszak, Sebastian M., Franson, A, Schwartz, J, Jain, R, Kachman, M, Baum, H, Burant, CF, Mottl, SL, Cartaxo, RT, John, V, Messinger, D, Sweha, StefanR, Qin, T, Peterson, E, Sajjakulnukit, P, Ravi, K, Waugh, A, Walling, D, Ding, Y, Xia, Z, Schwendeman, A, Hawes, D, Mota, Mateus, Yang, F, Judkins, AR, Wahl, D, Lyssiotis, CA, de la Nava, D, Alonso, MM, Eze, A, Spitzer, J, Schmidt, SV, Duchatel, Ryan J., Pun, Matthew, Dun, Matthew D., Cain, JE, Jiang, L, Stopka, SA, Baquer, G, Regan, MS, Filbin, MG, Agar, NYR, Zhao, L, Kumar-Sinha, C, Deogharkar, Akash, Mody, R, Chinnaiyan, A, Kurokawa, R, Pratt, D, Yadav, VN, Grill, J, Kline, C, Mueller, S, Resnick, A, Nazarian, J, Chung, Chan, Allen, JE, Odia, Y, Gardner, SL, Koschmann, C, Tarapore, Rohinton S.

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

- Jackson, Evangeline R., Duchatel, Ryan J., Le Grand, Marion, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Staudt, Dilana E., Smith, Nathan D., Day, B, Manoharan, N, Nagabushan, S, Hansford, JR, Govender, D, McCowage, GB, Firestein, R, Howlett, M, Endersby, R, Persson, Mika L., Gottardo, NG, Alvaro, F, Waszak, SM, Larsen, MR, Colino-Sanguino, Y, Valdés-Mora, F, Rakotomalala, A, Meignan, S, Pasquier, E, Andre, N, Mannan, Abdul, Hulleman, E, Eisenstat, DD, Vitanza, NA, Nazarian, J, Koschmann, C, Mueller, S, Cain, JE, Dun, MD, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N.

Time to Introduce Nerve Density in Cancer Histopathological Assessment

- Hondermarck, Hubert, Jiang, Chen Chen

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers

- McLachlan, Tabitha, Matthews, William C., Dun, Matthew D., Jackson, Evangeline R., Staudt, Dilana E., Douglas, Alicia M., Findlay, Izac J., Persson, Mika L., Duchatel, Ryan J., Mannan, Abdul, Germon, Zacary P.

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up

- Mathers, John C., Elliott, Faye, Lindblom, Annika, Morrison, Patrick J., Rashbass, Jem, Ramesar, Raj S., Seppälä, Toni T., Thomas, Huw J. W., Sheth, Harsh J., Pylvänäinen, Kirsi, Reed, Lynn, Borthwick, Gillian M., Macrae, Finlay, Bishop, D. Timothy, Burn, J, Boussioutas, A, Brewer, C, Cook, J, Eccles, D, Ellis, A, Hodgson, SV, Lubinski, J, Maher, ER, Mecklin, Jukka-Pekka, Porteous, MEM, Sampson, J, Scott, Rodney J., Side, L, Bisgaard, ML, Chu, C, Fidalgo, P, Gallinger, S, Homfray, T, Möslein, Gabriela, Hutter, P, Leite, J, MacKay, J, Marks, CG, Miles, A, Murday, V, Oliani, C, Olschwang, S, Segura, PP, Pichert, G, McRonald, Fiona E., Sappino, AP, Tempesta, A, Vasen, HFA, Walpole, I, Langman, C, Shand, B, Bacon, A, Bertario, Lucio, Evans, D. Gareth, Gerdes, Anne-Marie, Ho, Judy W. C.

Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer

- Distefano, Rosario, Tomasello, Luisa, Ma, Qin, Nigita, Giovanni, Croce, Carlo M., Rampioni Vinciguerra, Gian Luca, Gasparini, Pierluigi, Xiang, Yujia, Bagnoli, Marina, Marceca, Gioacchino P., Fadda, Paolo, Laganà, Alessandro, Acunzo, Mario

Characteristics associated with the use of diagnostic prostate biopsy and biopsy outcomes in Australian men

- Chiam, Karen, Bang, Albert, Patel, Manish I., Nair-Shalliker, Visalini, O'Connell, Dianne L., Smith, David P.

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

- Glubb, Dylan M., Thompson, Deborah J., Bermisheva, Marina, McNeish, IA, Menon, U, Modugno, F, Moysich, KB, Nevanlinna, H, Odunsi, K, Olsson, H, Orsulic, S, Osorio, A, Palli, D, Bernardini, Marcus Q., Park-Simon, T-W, Pearce, CL, Pejovic, T, Permuth, JB, Podgorska, A, Ramus, SJ, Rebbeck, TR, Riggan, MJ, Risch, HA, Rothstein, JH, Bischof, Katharina, Runnebaum, IB, Scott, RJ, Sellers, TA, Senz, J, Setiawan, VW, Siddiqui, N, Sieh, W, Spiewankiewicz, B, Sutphen, R, Swerdlow, AJ, Bjorge, Line, Szafron, LM, Teo, SH, Thompson, PJ, Thomsen, LCV, Titus, L, Tone, A, Tumino, R, Turman, C, Vanderstichele, A, Edwards, DV, Bodelon, Clara, Vergote, I, Vierkant, RA, Wang, Z, Wang-Gohrke, S, Webb, PM, White, E, Whittemore, AS, Winham, SJ, Wu, X, Wu, AH, Brand, Alison H., Yannoukakos, D, Spurdle, AB, O'Mara, TA, Brenton, James D., Brinton, Louise A., Bruinsma, Fiona, Buchanan, Daniel D., Aben, Katja K. H., Burghaus, S, Butzow, R, Cai, H, Carney, ME, Chanock, SJ, Chen, C, Chen, XQ, Chen, Z, Cook, LS, Cunningham, JM, Alsulimani, Ahmad, De Vivo, I, DeFazio, A, Doherty, JA, Dork, T, du Bois, A, Dunning, AM, Durst, M, Edwards, T, Edwards, RP, Ekici, AB, Amant, Frederic, Ewing, A, Fasching, PA, Ferguson, S, Flanagan, JM, Fostira, F, Fountzilas, G, Friedenreich, CM, Gao, B, Gaudet, MM, Gawelko, J, Annibali, Daniela, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goodman, MT, Gronwald, J, Harris, HR, Harter, P, Hein, A, Heitz, F, Hildebrandt, MAT, Attia, John, Hillemanns, P, Hogdall, E, Hogdall, CK, Holliday, Elizabeth G., Huntsman, DG, Huzarski, T, Jakubowska, A, Jensen, A, Jones, ME, Karlan, BY, Barricarte, Aurelio, Karnezis, A, Kelley, JL, Khusnutdinova, E, Killeen, JL, Kjaer, SK, Klapdor, R, Kobel, M, Konopka, B, Konstantopoulou, I, Kopperud, RK, Beckmann, Matthias W., Koti, M, Kraft, P, Kupryjanczyk, J, Lambrechts, D, Larson, MC, Le Marchand, L, Lele, S, Lester, J, Li, AJ, Liang, D, Berchuck, Andrew, Liebrich, C, Lipworth, L, Lissowska, J, Lu, L, Lu, KH, Macciotta, A, Mattiello, A, May, T, McAlpine, JN, McGuire, V

Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

- Chen, Jingwei, Nelson, Christopher, Wong, Matthew, Tee, Andrew E., Liu, Pei Y., La, Ting, Fletcher, Jamie I., Kamili, Alvin, Mayoh, Chelsea, Bartenhagen, Christoph, Trahair, Toby N., Xu, Ning, Jayatilleke, Nisitha, Wong, Marie, Peng, Hui, Atmadibrata, Bernard, Cheung, Belamy B., Lan, Qing, Bryan, Tracy M., Mestdagh, Pieter, Vandesompele, J, Combaret, V, Boeva, V, Wang, JY, Janoueix-Lerosey, I, Cowley, MJ, MacKenzie, KL, Dolnikov, A, Li, J, Polly, P, Marshall, GM, Reddel, RR, Norris, MD, Haber, M, Fischer, M, Zhang, Xu D., Pickett, HA, Liu, T

The emerging roles of rna m6a methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance

- Lan, Qing, Liu, Pei Y., Bell, Jessica L., Wang, Jenny Y., Hüttelmaier , Stefan, Zhang, Xu Dong, Zhang, Lirong, Liu, Tao

The future burden of head and neck cancers attributable to modifiable behaviors in Australia: A pooled cohort study

- Laaksonen, Maarit A., Canfell, Karen, Mitchell, Paul, Cumming, Robert G., Salagame, Usha, Vajdic, Claire M., MacInnis, Robert J., Banks, Emily, Byles, Julie E., Giles, Graham G., Magliano, Dianna J., Shaw, Jonathan E., Hirani, Vasant, Gill, Tiffany K.

Tumor neurobiology and the war of nerves in cancer

- Faulkner, Sam, Jobling, Phillip, March, Brayden, Jiang, Chen Chen, Hondermarck, Hubert

A p53-responsive miRNA network promotes cancer cell quiescence

- La, Ting, Liu, Guang Zhi, Guo, Su Tang, Liu, Tao, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong, Farrelly, Margaret, Cole, Nicole, Feng, Yu Chen, Zhang, Yuan Yuan, Sherwin, Simonne K., Yari, Hamed, Tabatabaee, Hessam, Yan, Xu Guang

Skp2-mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress

- Wang, Jia Yu, Liu, Guang Zhi, Jin, Lei, Wilmott, James S., La, Ting, Feng, Yu Chen, Yari, Hamed, Yan, Xu Guang, Thorne, Rick F., Scolyer, Richard A., Zhang, Xu Dong

The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription

- Wong, Matthew, Tee, Andrew E. L., Liu, Pei Yan, Zhang, Xu Dong, Hüttelmaier, Stefan, Wong, Jason W. H., Wang, Jenny, Polly, Patsie, Perini, Giovanni, Scarlett, Christopher J., Liu, Tao, Milazzo, Giorgio, Bell, Jessica L., Poulos, Rebecca C., Atmadibrata, Bernard, Sun, Yuting, Jing, Duohui, Ho, Nicholas, Ling, Dora

Antagonists of IGF: Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions

- Kashyap, Abhishek S., Shooter, Gary K., Hollier, Brett G., Shokoohmand, Ali, McGovern, Jacqui, Sivaramakrishnan, Manaswini, Croll, Tristan I., Cane, Gaëlle, Leavesley, David I., Söderberg, Ola, Upton, Zee

Genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer

- Painter, Jodie N., O'Mara, Tracy A., Scott, Rodney J., Ahmed, Shahana, Healey, Catherine S., Shah, Mitul, Gorman, Maggie, Martin, Lynn, Hodgson, Shirley V., Beckmann, Matthias W., Ekici, Arif B., Fasching, Peter A., Marquart, Louise, Hein, Alexander, Rübner, Matthias, Czene, Kamilla, Darabi, Hatef, Hall, Per, Li, Jingmei, Dörk, Thilo, Dürst, Matthias, Hillemanns, Peter, Runnebaum, Ingo B., Webb, Penelope M., Amant, Frederic, Annibali, Daniela, Depreeuw, Jeroen, Lambrechts, Diether, Neven, Patrick, Cunningham, Julie M., Dowdy, Sean C., Goode, Ellen L., Fridley, Brooke L., Winham, Stacey J., Attia, John, Njølstad, Tormund S., Salvesen, Helga B., Trovik, Jone, Werner, Henrica M. J., Ashton, Katie A., Otton, Geoffrey, Proietto, Anthony, Mints, Miriam, Tham, Emma, Bolla, Manjeet K., Medland, Sarah E., Michailidou, Kyriaki, Wang, Qin, Tyrer, Jonathan P., Hopper, John L., Peto, Julian, Swerdlow, Anthony J., Burwinkel, Barbara, Brenner, Hermann, Meindl, Alfons, Brauch, Hiltrud, Cheng, Timothy, Lindblom, Annika, Chang-Claude, Jenny, Couch, Fergus J., Giles, Graham G., Kristensen, Vessela N., Cox, Angela, Pharoah, Paul D. P., Tomlinson, Ian, Dunning, Alison M., Easton, Douglas F., Dennis, Joe, Thompson, Deborah J., Spurdle, Amanda B., Holliday, Elizabeth G., McEvoy, Mark

Inhibition of HSP90 by AUY922 preferentially kills mutant KRAS colon cancer cells by activating Bim through ER stress

- Wang, Chun Yan, Guo, Su Tang, Wang, Jia Yu, Liu, Fen, Zhang, Yuan Yuan, Yari, Hamed, Yan, Xu Guang, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen